Publication | Closed Access

Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial

Phase 1BLymphoid NeoplasiaHematological MalignancyChronic Lymphocytic LeukaemiaMedicineHematologyClinical TrialsImmunologyPharmacotherapyNon-inferiority TrialImmunotherapyOncologyHealth Sciences